Member Profile ohm20 | Latest Posts

A mea culpa I should stop posting w

05/08/2025 2:44:55 PM

(5)

"Power supply in my other computer"

05/08/2025 1:56:23 PM

So we have this promising data. Per

05/08/2025 1:49:40 PM

"Tiny, one more point to add to you

05/08/2025 1:38:14 PM

(12)

And good luck to you I don't need l

05/08/2025 7:35:21 AM

(31)

Isn’t it 19.8 divided by .7= 28.3

05/08/2025 7:28:47 AM

(5)

Humor often doesn't depend on truth

05/08/2025 6:53:38 AM

Coming from someone, apparently ded

05/08/2025 6:51:33 AM

(5)

I also had ChatGPT break it down fo

05/08/2025 6:43:45 AM

(4)

Staphylococcus Uses CCR 5 to access

05/08/2025 6:15:09 AM

Only 3 of the 28 patients had the o

05/08/2025 3:07:17 AM

“Do you think 28 patients is too

05/08/2025 2:50:04 AM

Could it put an end to lymphedema?

05/08/2025 2:42:05 AM

So, given Leronlimab was called int

05/08/2025 12:06:58 AM

(13)

If you were going to edit the abstr

05/07/2025 10:48:52 PM

"In other words...Leronlimab is at

05/07/2025 10:37:22 PM

(13)

What do we think about the low mOS?

05/07/2025 10:29:08 PM

Key differences: • ASCENT Trial (

05/07/2025 10:18:12 PM

(7)

Would it be fair to assume that mea

05/07/2025 8:52:55 PM

There seems to be a couple of mista

05/07/2025 8:29:43 PM

(24)

Ohm and others - given the results

05/07/2025 7:30:04 PM

(10)

For pembrolizumab + standard chemot

05/07/2025 7:15:40 PM

But is that survival rate for Trold

05/07/2025 6:56:06 PM

sacituzumab govitecan (ASCENT) (mO

05/07/2025 6:51:58 PM

(22)

An added note: CISH, Tregs, PD-1 an

05/07/2025 6:16:57 PM

(18)

I don't have good sources and not s

05/07/2025 5:47:45 PM

(21)

So, here's where I think about the

05/07/2025 3:20:25 PM

But most often ( if not always ) to

05/07/2025 7:31:05 AM

(4)

Not sure if they ever disclosed rec

05/07/2025 7:13:41 AM

(9)

and the protocol will soon be submi

05/07/2025 6:33:50 AM

(4)

December 2024 Third, we have finali

05/06/2025 2:28:05 PM

(3)

Ken , all what is important now for

05/06/2025 11:05:16 AM

With ESMO on everyone’s brain you

05/06/2025 10:37:43 AM

(19)

I love the idea of LL making a diff

05/06/2025 8:22:55 AM

(9)

So I've asked multiple times if som

05/06/2025 8:01:11 AM

(7)

One of the problems with AI is that

05/05/2025 7:49:58 PM

(26)

How do you think the combination b/

05/05/2025 5:03:39 PM

Now to say the complete opposite (t

05/05/2025 4:37:24 PM

(17)

dostarlimab gets 'star' treatment o

05/05/2025 1:20:18 PM

Leron occupies the CCR5 receptor.

05/05/2025 1:08:20 PM

(17)

Does an initial normal low CCR5 sit

05/05/2025 12:52:06 PM

(17)

Ohm is probably just writing a play

05/05/2025 9:14:34 AM

What is FDA doing, why hasn’t BTD

05/05/2025 9:07:19 AM

(13)

it seems to me you could come up wi

05/05/2025 8:56:52 AM

(18)

Do we think that Leronlimab is a ti

05/05/2025 8:29:00 AM

(38)

CytoDyn Leadership Team To Attend E

05/04/2025 5:17:56 PM

(36)

Is Gilead hoping that Merck would w

05/04/2025 4:07:21 PM

(21)

I thought I'd better comment before

05/04/2025 3:28:48 PM

(23)

Interesting observation. LL was stu

04/10/2025 11:43:41 PM